These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20473325)

  • 1. Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53.
    Fishler T; Li YY; Wang RH; Kim HS; Sengupta K; Vassilopoulos A; Lahusen T; Xu X; Lee MH; Liu Q; Elledge SJ; Ried T; Deng CX
    Oncogene; 2010 Jul; 29(28):4007-17. PubMed ID: 20473325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
    Liu Q; Guntuku S; Cui XS; Matsuoka S; Cortez D; Tamai K; Luo G; Carattini-Rivera S; DeMayo F; Bradley A; Donehower LA; Elledge SJ
    Genes Dev; 2000 Jun; 14(12):1448-59. PubMed ID: 10859164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation.
    Adams JR; Xu K; Liu JC; Agamez NM; Loch AJ; Wong RG; Wang W; Wright KL; Lane TF; Zacksenhaus E; Egan SE
    Cancer Res; 2011 Apr; 71(7):2706-17. PubMed ID: 21324922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instability.
    Ray D; Terao Y; Fuhrken PG; Ma ZQ; DeMayo FJ; Christov K; Heerema NA; Franks R; Tsai SY; Papoutsakis ET; Kiyokawa H
    Cancer Res; 2007 Feb; 67(3):984-91. PubMed ID: 17283130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
    Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway.
    Vitale I; Galluzzi L; Vivet S; Nanty L; Dessen P; Senovilla L; Olaussen KA; Lazar V; Prudhomme M; Golsteyn RM; Castedo M; Kroemer G
    PLoS One; 2007 Dec; 2(12):e1337. PubMed ID: 18159231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.
    Zaugg K; Su YW; Reilly PT; Moolani Y; Cheung CC; Hakem R; Hirao A; Liu Q; Elledge SJ; Mak TW
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3805-10. PubMed ID: 17360434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.
    Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H
    Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk1 is essential for tumor cell viability following activation of the replication checkpoint.
    Cho SH; Toouli CD; Fujii GH; Crain C; Parry D
    Cell Cycle; 2005 Jan; 4(1):131-9. PubMed ID: 15539958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAP80 is critical in maintaining genomic stability and suppressing tumor development.
    Yin Z; Menendez D; Resnick MA; French JE; Janardhan KS; Jetten AM
    Cancer Res; 2012 Oct; 72(19):5080-90. PubMed ID: 22896338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA resection protein CtIP promotes mammary tumorigenesis.
    Reczek CR; Shakya R; Miteva Y; Szabolcs M; Ludwig T; Baer R
    Oncotarget; 2016 May; 7(22):32172-83. PubMed ID: 27058754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chk1 is haploinsufficient for multiple functions critical to tumor suppression.
    Lam MH; Liu Q; Elledge SJ; Rosen JM
    Cancer Cell; 2004 Jul; 6(1):45-59. PubMed ID: 15261141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis.
    Tho LM; Libertini S; Rampling R; Sansom O; Gillespie DA
    Oncogene; 2012 Mar; 31(11):1366-75. PubMed ID: 21804609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Checkpoint kinase 1 is essential for fetal and adult hematopoiesis.
    Schuler F; Afreen S; Manzl C; Häcker G; Erlacher M; Villunger A
    EMBO Rep; 2019 Aug; 20(8):e47026. PubMed ID: 31379128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.